Lusutrombopag for Severe Thrombocytopenia in Patients with Hepatocellular Carcinoma

Lusutrombopag was safe and effective in an integrated analysis of two phase III trials.

Source link

Related posts

Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway


Antibiotics May Cure Appendicitis—No Operation Needed


Dealing With Cancer in the 'Oldest Old' Patients


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy